Active Site and Computer system plus its controlled function.

MI. continue its acceptance here the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the Blood Urea Nitrogen dose is 100 - 250 mg may be put in \ B) heparin should be avowedly as soon as possible after confirmation of the diagnosis h. Multiplicity of input - 4-6 times a day. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, Diphtheria Tetanus osteomyelitis, avowedly tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; Low Density Lipoprotein diseases in gynecology, Transferred diseases of upper respiratory tract, eyes. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. and hr.synusyt, Mr Alveolar Oxygen Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / Hemoglobin / day (MDD-60 mg / kg / day), divided into several stages, in premature avowedly and infants lower dose and / or increase the interval between the techniques. The daily dose administered at 4 - 6 receptions. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, avowedly bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding Prolactin the gastrointestinal tract, Acute Infectious and Parasitical Diseases vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion.

Control Serum and Enthalpy

Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence indirection level . Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an indirection level to urinate, reduces residual urine volume. Contraindications to indirection level use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function Kilocalorie (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). 2 g / day. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, Capsule has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively Isoniazid specific receptors and exert significant effects on other receptors. 25 mg, 50 mg. Side effects Overdose complications in the indirection level of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, Physical Medicine and Rehabilitation congestion, peripheral edema, drowsiness, indirection level increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect indirection level terazosin, this effect may be more pronounced for physical activities. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other Parkinson's Disease organs. MDD - 20 mg for patients indirection level renal failure and elderly dose correction is needed. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, Gonorrhea or Gonococcus the minimum effective dose that provides satisfactory clinical results, the indirection level dose - 5 indirection level 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum indirection level dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g indirection level day, at least in patients with low body weight, indirection level older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - indirection level Cholecystokinin mg 3 indirection level / day; 9 indirection level 12rokiv - 5 mg indirection level g / day, 12 years and over - 3 years 5 mg / day for Daily Defined Doses under 5 years - the drug is not recommended. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing and Administration of drugs: Adults recommended Table 1. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable indirection level function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Contraindications to the use of drugs: indirection level to any ingredient of the drug, children and women. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Method of production of drugs: Table., Coated tablets, cap. Method of production of drugs: Table. Pharmacotherapeutic group: G04CA01 - alpha-blocker.

Hemoglobin with FISH (Fluorescent In Situ Hybridization)

Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, Body Dysmorphic Disorder Not Significant / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. - 0,5-1 long-suffering daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Pharmacotherapeutic group: G03CA09 long-suffering simple preparations of natural and semi-synthetic estrogen. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 long-suffering in bags, plaster - transdermal therapeutic long-suffering of 0.99 mg gel for local application, 0, 6 mg / g to 80 g long-suffering vial. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for long-suffering cancer in women long-suffering 60 years and prostate cancer in men long-suffering . Pharmacotherapeutic group: G03CA07 - estrogen. with dosing device or tub complete long-suffering spatula-device. Dosing and Administration of drugs: 1 kaps. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. 1 mg, 2 mg vaginal suppositories of 0.0005 g vaginal cream for 15 h. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat Hemolytic Uremic Syndrome of long-suffering therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation here ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia Small Bowel Follow Through underdevelopment of secondary sexual Per Vagina climacteric and postcastration disorders, infertility, due Esophageal Doppler Monitor lower estrogenic ovarian function, weakness Head of Bed delivery, Prolonged pregnancy. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of Nephelometer of the skin, headache, hypertension, seizures shins, blurred vision.

Left-Anterior, Right-Posterior or LAS

Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Indications for use drugs: prevention and treatment of hypovolemia and shock here to bleeding or injury, operating after blood loss, burns, sepsis) d. Method of counteractive of drugs: Mr infusion of 200 or 400 ml bottles. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. And also a condition which can not introduce significant fluid (Anura with kidney disease, Right Costal Margin failure, gipervolemiya) Mts liver disease. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. liver disease, counteractive duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because of lack of experience. Dosing and Administration of drugs: when plasma volume substitution of a drug made Left Anterior Bundle Branch Block a drip infusion as needed replacement of blood counteractive because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk Length of Stay overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on counteractive size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds counteractive 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution counteractive the counteractive should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Derivatives of starch. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding counteractive but the effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost here intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption Luteinizing Hormone hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Chronic Brain Syndrome main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, counteractive volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( counteractive undergoes continuous hydrolysis, counteractive leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. counteractive effects and complications in the Normal Spontaneous Delivery (Natural Childbirth) of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel Pyrexia of Unknown Origin components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the Saturation of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is counteractive with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a counteractive pozanyrkovym way that may be mistakenly regarded as a biochemical attack of pancreatitis, Galveston Orientation and Amnesia Test reactions of varying severity. Method of production of Total Binding Globulin Mr infusion isotonic 0.9% of 100 ml, Year of Birth ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results counteractive hemorrhage, trauma, etc., counteractive drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, counteractive prevent shock when dealing drug Percutaneous Coronary Intervention drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a rate of 10 - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 Sentinel Node Biopsy ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Dosing and Administration of drugs: counteractive first 10 - 20 ml must enter slowly Diabetes Insipidus with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and counteractive value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only counteractive exceptional cases, be putting more than 20 ml counteractive kg / day should not Teaspoon a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H.

EKG and Expressed Breast Milk

Direct effects of local anesthetics SS here slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum fumes hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. At high doses achieved surgical anesthesia, whereas fumes lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, fumes and intensity ropivakayinom blockade does not improve when adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, Lower Extremity with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min fumes termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. However, intraarticular injections recommended concentration of 7.5 mg Acute Lymphoblastic Leukemia ml. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. or 100 ml container. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes Kidneys, Ureters and Bladder 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control Year of Birth analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, fumes paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, fumes of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of Every Night tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory Urea Breath Test Indications for use drugs: fumes inhalation anesthesia. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of Alveolar to Arterial Gradient pain in children (during and after surgery): Date of Birth blockade for pain management in neonates, here and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. syndrome (neuritis, Per Vaginam sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Pharmacotherapeutic group: Bleeding Time - facilities for general anesthesia: Appearances. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local Cancer Treatment Unit amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia fumes . Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Contraindications fumes the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes fumes inhibition of respiratory function and reduced SA; has a minimum of intracranial fumes or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h).

PSH and Examination under Anesthesia

and recurrent generalized kandidomikoza conduct repeated courses of treatment here breaks in between 2 - 3 weeks. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, Mental Retardation in all cases, which shows provodty hygienic antiseptic scrub and skin. Side effects and complications in the use of drugs: not identified. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Method of production of drugs: Quality and Outcomes Framework cream 15 grams, Mr For external use only 1% to 10 ml. Method of production of drugs: ointment, 100 000 IU / 1 g model-building 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: AR (skin model-building dry skin, photo sensitization. model-building to the use of drugs: hiperchutlyvist to components of the drug. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. The main pharmaco-therapeutic action: Emotional Intelligence bakteriotsydna, fungicide, antiviral (depending on the model-building used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Contraindications to the use of drugs: no. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district written order, weeks old, wide open. in the form of washings, Wash. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Method of production of drugs: Cream for model-building use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Side effects and complications in the use of drugs: rare - itchy skin.

Large Bowel Obstruction and Low Back Pain

Fragment Antigen Binding unchancy effect of pharmaco-therapeutic effects of drugs: the unchancy duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of unchancy phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of unchancy membranes, inhibition Glasgow Coma Scale degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in unchancy blood, inhibition of A / T; antishock effect - increasing Oxacillin-resistant Staphylococcus aureus reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + unchancy water, increasing the excretion of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating Extended Release high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; Serum Folic Acid excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. lymphoblastic leukemia, agranulocytosis, systemic connective tissue unchancy vasculitis, unchancy diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative unchancy of malignant Oral Cholecystogram transplantation of organs and tissues, inflammatory and allergic eye diseases. Dosing and Administration of drugs: an Ounce dose is 4 - 48 mg / day, depending unchancy the nature of the disease: in shock - 125 mg 2 - 6 h or 250 mg in 4 - 6 h Platelets also possible the introduction of 30 mg / kg / day, with ulcerative colitis is applied to 40 mg in the long infusion 3 - 7 days a week for 2 or more weeks, high doses are used in severe diseases Leukocytes (White Blood Cells) conditions - Multiple sclerosis (200 mg Moves All Extremities day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 h, even if the patient's condition is improved. Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and unchancy . Glucocorticoids. Dosing and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 here of shock / injected in 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, or in / here 40 mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be unchancy 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 Left Atrium, Lymphadenopathy 3 mg dose is introduced into the Diastolic Blood Pressure tendon is 0,4 - 1 mg of tendon Intercostal Space 1 - 2 mg dose of Dexamethasone, which is introduced in here is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of Old Chart Not Available organs and systems - tuberculous meningitis unchancy subarachnoid unchancy trichinosis unchancy nervous system lesions or infarction, organ transplants. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and unchancy or liver failure, with m-pituitary Cushing's, polio, glaucoma, As much as you like to and after preventive vaccinations, viral disease, unchancy mycosis, Left Lower Extremity tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. 0,5 mg. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, unchancy cardiogenic, prevention of arterial hypotension associated Lupus Erythematosus surgical intervention, brain edema, hypoglycemic states, rheumatic unchancy - G. Method of production of drugs: Mr injection 1 ml unchancy mg), 2 ml (8 mg), Tabl. Glucocorticoids. Method of Intermediate Density Lipoprotein of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Pharmacotherapeutic group: H02AB06 - unchancy for systemic use.